Not Available
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
Half-life | 15.0 | h | 15 | h | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Frequency | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|---|
Max dose for children | 230.0 | mg/m2 | 230 | mg/m2 | bid | Tasigna | nilotinib | PDR | |
Max dose for children | 400.0 | mg/dose | 400 | mg/dose | Tasigna | nilotinib | PDR | ||
Max dose for adolescents | 230.0 | mg/m2/day | 230 | mg/m2/day | bid | Tasigna | nilotinib | PDR | |
Max dose for adolescents | 400.0 | mg/dose | 400 | mg/dose | Tasigna | nilotinib | PDR | ||
Max dose for adults | 800.0 | mg/day | 800 | mg/day | PO, oral | Tasigna | nilotinib | PDR | |
Max dose for geriatric | 800.0 | mg/day | 800 | mg/day | PO, oral | Tasigna | nilotinib | PDR |